Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""ADULTS"" wg kryterium: Temat


Starter badań:

Tytuł:
The continuous spectrum of glycaemic variability changes with pancreatic islet function: A multicentre cross-sectional study in China.
Autorzy:
Zhang L; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Guo K; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Tian Q; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Ye J; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Ding Z; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Zhou Q; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Wu J; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Fan L; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Pan N; Department of Endocrinology, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, China.
Niu X; Department of Endocrinology, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, China.
Zhao Q; The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang Clinical Medicine Research Center of Endocrine and Metabolic Diseases, Luoyang, China.
Ma Y; The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang Clinical Medicine Research Center of Endocrine and Metabolic Diseases, Luoyang, China.
Jiang H; The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang Clinical Medicine Research Center of Endocrine and Metabolic Diseases, Luoyang, China.
Huang G; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Li X; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Zhou Z; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Yang L; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Pokaż więcej
Źródło:
Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2022 Nov; Vol. 38 (8), pp. e3579. Date of Electronic Publication: 2022 Oct 25.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 1*
Diabetes Mellitus, Type 2*
Latent Autoimmune Diabetes in Adults*
Islets of Langerhans*
Adult ; Humans ; Blood Glucose/analysis ; Blood Glucose Self-Monitoring ; C-Peptide ; Cross-Sectional Studies
Czasopismo naukowe
Tytuł:
Latent autoimmune diabetes in youth shows greater autoimmunity than latent autoimmune diabetes in adults: Evidence from a nationwide, multicenter, cross-sectional study.
Autorzy:
Cheng J; Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China.; Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, China.
Tang X; Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China.; Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, China.
Yan X; Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China.; Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, China.
Huang G; Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China.; Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, China.
Luo S; Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China.; Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, China.
Zhou Z; Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China.; Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, China.
Li X; Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China.; Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, China.
Pokaż więcej
Źródło:
Pediatric diabetes [Pediatr Diabetes] 2022 Aug; Vol. 23 (5), pp. 578-587. Date of Electronic Publication: 2022 May 17.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 1*/epidemiology
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/epidemiology
Glucose Intolerance*
Insulin Resistance*
Latent Autoimmune Diabetes in Adults*/diagnosis
Latent Autoimmune Diabetes in Adults*/epidemiology
Metabolic Syndrome*/epidemiology
Adolescent ; Adult ; Autoantibodies ; Autoimmunity ; China ; Cross-Sectional Studies ; Glutamate Decarboxylase ; Humans ; Young Adult
Czasopismo naukowe
Tytuł:
Analysis of detrended fluctuation function derived from continuous glucose monitoring may assist in distinguishing latent autoimmune diabetes in adults from T2DM.
Autorzy:
Zhang L; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Tian Q; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Guo K; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Wu J; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Ye J; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Ding Z; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Zhou Q; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Huang G; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Li X; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Zhou Z; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Yang L; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Sep 20; Vol. 13, pp. 948157. Date of Electronic Publication: 2022 Sep 20 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 1*
Diabetes Mellitus, Type 2*
Glucose Intolerance*
Latent Autoimmune Diabetes in Adults*/diagnosis
Adult ; Blood Glucose ; Blood Glucose Self-Monitoring ; C-Peptide ; Humans
Czasopismo naukowe
Tytuł:
Efficacy and safety of sitagliptin and insulin for latent autoimmune diabetes in adults: A systematic review and meta-analysis.
Autorzy:
Lin T; The First School of Clinical Medical Sciences, Guangzhou University of Chinese, Medicine, Guangzhou, China.
Cai Y; The First School of Clinical Medical Sciences, Guangzhou University of Chinese, Medicine, Guangzhou, China.
Tang L; Department of Endocrinology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Lian Y; The First School of Clinical Medical Sciences, Guangzhou University of Chinese, Medicine, Guangzhou, China.
Liu M; Department of Endocrinology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Liu C; Department of Endocrinology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Pokaż więcej
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2022 Sep; Vol. 13 (9), pp. 1506-1519. Date of Electronic Publication: 2022 May 06.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Diabetes Mellitus, Type 2*/drug therapy
Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use
Latent Autoimmune Diabetes in Adults*/drug therapy
Adult ; C-Peptide ; Glycated Hemoglobin A ; Humans ; Hypoglycemic Agents/therapeutic use ; Insulin/therapeutic use ; Randomized Controlled Trials as Topic ; Sitagliptin Phosphate/therapeutic use
Czasopismo naukowe
Tytuł:
Editorial: Latent Autoimmune Diabetes in Adults (LADA).
Autorzy:
Leslie RD; Immunobiology Department, Queen Mary University of London, London, United Kingdom.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Aug 29; Vol. 13, pp. 1002776. Date of Electronic Publication: 2022 Aug 29 (Print Publication: 2022).
Typ publikacji:
Editorial
MeSH Terms:
Diabetes Mellitus, Type 1*/therapy
Diabetes Mellitus, Type 2*
Latent Autoimmune Diabetes in Adults*/diagnosis
Latent Autoimmune Diabetes in Adults*/epidemiology
Latent Autoimmune Diabetes in Adults*/therapy
Humans
Opinia redakcyjna
Tytuł:
Latent autoimmune diabetes in adults in China.
Autorzy:
Qiu J; Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, China.
Xiao Z; Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, China.
Zhang Z; Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, China.
Luo S; Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, China.
Zhou Z; Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2022 Aug 25; Vol. 13, pp. 977413. Date of Electronic Publication: 2022 Aug 25 (Print Publication: 2022).
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 1*/epidemiology
Diabetes Mellitus, Type 1*/genetics
Diabetes Mellitus, Type 2*/epidemiology
Diabetes Mellitus, Type 2*/genetics
Latent Autoimmune Diabetes in Adults*/epidemiology
Latent Autoimmune Diabetes in Adults*/genetics
Adult ; Asians ; China/epidemiology ; Humans
Czasopismo naukowe
Tytuł:
Genetics: Is LADA just late onset type 1 diabetes?
Autorzy:
Hernández M; Department of Endocrinology and Nutrition, University Hospital Arnau de Vilanova, Lleida, Spain.; Lleida Biomedical Research Institute (IRB Lleida), University of Lleida (UdL), Lleida, Spain.
Nóvoa-Medina Y; Department of Pediatrics, Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, Spain.; Research Institute in Biomedical and Health Sciences (IUIBS), University of Las Palmas de Gran Canaria (ULPGC), Las Palmas de Gran Canaria, Spain.
Faner R; Histocompatibility and Immunogenetics Laboratory, Blood and Tissue Bank, Barcelona, Spain.
Palou E; Histocompatibility and Immunogenetics Laboratory, Blood and Tissue Bank, Barcelona, Spain.
Esquerda A; Department of Laboratory Medicine, University Hospital Arnau de Vilanova, Lleida, Spain.
Castelblanco E; Diabetis en Atenció Primària - Catalunya (DAP-Cat) Group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, Barcelona, Spain.; Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine in St. Louis, St. Louis, MO, United States.
Wägner AM; Research Institute in Biomedical and Health Sciences (IUIBS), University of Las Palmas de Gran Canaria (ULPGC), Las Palmas de Gran Canaria, Spain.; Department of Endocrinology and Nutrition, Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, Spain.
Mauricio D; Department of Endocrinology, Hospital de la Santa Creu i Sant Pau & Institut d'Investigació Biomèdica (IIB) Sant Pau, Barcelona, Spain.; Consorcio Centro de Investigación Biomédica en Red (CIBER) of Diabetes and Associated Metabolic Diseases, Instituto de Salud Carlos III, Barcelona, Spain.; Faculty of Medicine, University of Vic & Central University of Catalonia, Vic, Spain.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Aug 10; Vol. 13, pp. 916698. Date of Electronic Publication: 2022 Aug 10 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 1*
Diabetes Mellitus, Type 2*
Latent Autoimmune Diabetes in Adults*
Adult ; Age of Onset ; Cross-Sectional Studies ; Genetic Predisposition to Disease ; Humans ; Protein Tyrosine Phosphatase, Non-Receptor Type 22
Czasopismo naukowe
Tytuł:
Latent autoimmune diabetes in adults: a focus on β-cell protection and therapy.
Autorzy:
Yin W; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Luo S; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Xiao Z; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Zhang Z; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Liu B; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Zhou Z; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Aug 05; Vol. 13, pp. 959011. Date of Electronic Publication: 2022 Aug 05 (Print Publication: 2022).
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 1*/therapy
Diabetes Mellitus, Type 2*
Islets of Langerhans*
Latent Autoimmune Diabetes in Adults*/therapy
Adult ; Cytoprotection ; Disease Progression ; Humans
Czasopismo naukowe
Tytuł:
Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto's thyroiditis: a case report.
Autorzy:
Xenou M; Mediterranean Diabetes and Obesity Clinics (MEDOC), Athens, Santorini, Greece.; Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Zoupas I; Mediterranean Diabetes and Obesity Clinics (MEDOC), Athens, Santorini, Greece. .; Medical School, National and Kapodistrian University of Athens, Athens, Greece. .
Lygnos D; Mediterranean Diabetes and Obesity Clinics (MEDOC), Athens, Santorini, Greece.
Fousteris E; Mediterranean Diabetes and Obesity Clinics (MEDOC), Athens, Santorini, Greece.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2022 Aug 03; Vol. 16 (1), pp. 297. Date of Electronic Publication: 2022 Aug 03.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 1*/complications
Diabetic Ketoacidosis*/diagnosis
Diabetic Ketoacidosis*/drug therapy
Hashimoto Disease*/complications
Hashimoto Disease*/diagnosis
Hashimoto Disease*/drug therapy
Latent Autoimmune Diabetes in Adults*/diagnosis
Latent Autoimmune Diabetes in Adults*/drug therapy
Metformin*
Thyrotoxicosis*
Adult ; Autoantibodies ; Humans ; Insulin/therapeutic use ; Male
Czasopismo naukowe
Tytuł:
Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy.
Autorzy:
Hu J; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Zhang R; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Zou H; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Xie L; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Zhou Z; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Xiao Y; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Jul 21; Vol. 13, pp. 917169. Date of Electronic Publication: 2022 Jul 21 (Print Publication: 2022).
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 1*/drug therapy
Diabetes Mellitus, Type 2*/genetics
Glucose Intolerance*
Latent Autoimmune Diabetes in Adults*/therapy
Adult ; Humans ; Immunologic Factors/therapeutic use ; Immunotherapy
Czasopismo naukowe
Tytuł:
Latent Autoimmune Diabetes in Adults: Background, Safety and Feasibility of an Ongoing Pilot Study With Intra-Lymphatic Injections of GAD-Alum and Oral Vitamin D.
Autorzy:
Björklund A; Department of Molecular medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Endocrine and Diabetes Unit, Karolinska University Hospital, Stockholm, Sweden.; Diabetes Center, Academic Specialist Center, Region Stockholm, Stockholm, Sweden.
Hals IK; Department of Endocrinology, Clinic of Medicine, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Nord-Trondelag Hospital Trust, Levanger, Norway.
Grill V; Department of Endocrinology, Clinic of Medicine, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Ludvigsson J; Division of Pediatrics, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.; Crown Princess Victoria Children´s Hospital, Linköping, Sweden.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Jul 18; Vol. 13, pp. 926021. Date of Electronic Publication: 2022 Jul 18 (Print Publication: 2022).
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 1*
Glucose Intolerance*/drug therapy
Latent Autoimmune Diabetes in Adults*/drug therapy
Adult ; Aged ; Alum Compounds ; Feasibility Studies ; Glutamate Decarboxylase/therapeutic use ; Humans ; Insulin/metabolism ; Middle Aged ; Pilot Projects ; Vitamin D/therapeutic use
Czasopismo naukowe
Tytuł:
Prevalence and factors associated with latent autoimmune diabetes in adults (LADA): a cross-sectional study.
Autorzy:
Manisha AM; Department Biochemistry, School of Medicine, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam, Tanzania. .; Department of Biochemistry and Physiology, Mwanza University, P.O. Box 1719, Mwanza, Tanzania. .
Shangali AR; Department of Biochemistry and Physiology, Mwanza University, P.O. Box 1719, Mwanza, Tanzania.; Department of Parasitology, Microbiology and Immunology, Mwanza University, P.O. Box 1719, Mwanza, Tanzania.
Mfinanga SG; National Institute for Medical Research, P.O. Box 3436, Dar es salaam, Tanzania.; Department of Epidemiology and Statistics, School of Public Health, Muhimbili University of Health, and Allied Science, P.O. Box 65001, Dar es Salaam, Tanzania.
Mbugi EV; Department Biochemistry, School of Medicine, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam, Tanzania.
Pokaż więcej
Źródło:
BMC endocrine disorders [BMC Endocr Disord] 2022 Jul 08; Vol. 22 (1), pp. 175. Date of Electronic Publication: 2022 Jul 08.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/epidemiology
Latent Autoimmune Diabetes in Adults*/complications
Latent Autoimmune Diabetes in Adults*/diagnosis
Latent Autoimmune Diabetes in Adults*/epidemiology
Adult ; Aged ; Aged, 80 and over ; Autoantibodies ; Cross-Sectional Studies ; Glutamate Decarboxylase ; Humans ; Longitudinal Studies ; Middle Aged ; Prevalence ; Quality of Life ; Tanzania
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz